<description>&lt;p&gt;Today on the show, Katie Martin and Rob Armstrong talk with special guest Adam Posen about the prospects for inflation and even a financial crisis. Posen has worked for both the Federal Reserve Bank of New York and the Bank of England, and is the current president of the non-profit Peterson Institute for International Economics. They talk about the options facing the next Fed chair, the conditions for serious inflation, and AI’s role in our economic future. Also they go short crypto and long the New England Patriots.&amp;nbsp;&lt;/p&gt;&lt;br&gt;&lt;p&gt;For a free 30-day trial to the Unhedged newsletter go to: &lt;a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank"&gt;https://www.ft.com/unhedgedoffer&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;You can email Robert Armstrong and Katie Martin at &lt;a href="mailto:unhedged@ft.com" rel="noopener noreferrer" target="_blank"&gt;unhedged@ft.com&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;&lt;a href="https://www.ft.com/content/c5040528-c2bc-467b-ad3c-d02d77b4cf48" rel="noopener noreferrer" target="_blank"&gt;&lt;strong&gt;Read a transcript of this episode on FT.com&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;hr&gt;&lt;p style='color:grey; font-size:0.75em;'&gt; Hosted on Acast. See &lt;a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'&gt;acast.com/privacy&lt;/a&gt; for more information.&lt;/p&gt;</description>

Weighing the weakening of institutions

Today on the show, Katie Martin and Rob Armstrong talk with special guest Adam Posen about the prospects for inflation and even a financial crisis. Posen has worked for both the Federal Reserve Bank of New York and the Bank of England, and is the current president of the non-profit Peterson Institute for International Economics. They talk about the options facing the next Fed chair, the conditions for serious inflation, and AI’s role in our economic future. Also they go short crypto and long the New England Patriots.&nbsp; For a free 30-day trial to the Unhedged newsletter go to: <a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank">https://www.ft.com/unhedgedoffer</a>. You can email Robert Armstrong and Katie Martin at <a href="mailto:unhedged@ft.com" rel="noopener noreferrer" target="_blank">unhedged@ft.com</a>. <a href="https://www.ft.com/content/c5040528-c2bc-467b-ad3c-d02d77b4cf48" rel="noopener noreferrer" target="_blank">Read a transcript of this episode on FT.com</a><hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

A satanic list of inflationary factors

<description>&lt;p&gt;Mature economies such as France, the UK and the US are spending more than they take in. They make up the rest in borrowing. But how long can that last? Today on the show, Katie Martin speaks with Ian Smith, the FT’s senior markets correspondent, about the UK’s latest Budget and bond sales, and what it means for governments around the globe. Also they go long chocolate and short cats.&amp;nbsp;&lt;/p&gt;&lt;br&gt;&lt;p&gt;For a free 30-day trial to the Unhedged newsletter go to: &lt;a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank"&gt;https://www.ft.com/unhedgedoffer&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;You can email Robert Armstrong and Katie Martin at &lt;a href="mailto:unhedged@ft.com" rel="noopener noreferrer" target="_blank"&gt;unhedged@ft.com&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;&lt;a href="https://www.ft.com/content/8d7dcd7c-bdb2-4755-8f93-17db32895661" rel="noopener noreferrer" target="_blank"&gt;&lt;strong&gt;Read a transcript of this episode on FT.com&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;hr&gt;&lt;p style='color:grey; font-size:0.75em;'&gt; Hosted on Acast. See &lt;a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'&gt;acast.com/privacy&lt;/a&gt; for more information.&lt;/p&gt;</description>

What can the world learn from the UK Budget?

Mature economies such as France, the UK and the US are spending more than they take in. They make up the rest in borrowing. But how long can that last? Today on the show, Katie Martin speaks with Ian Smith, the FT’s senior markets correspondent, about the UK’s latest Budget and bond sales, and what it means for governments around the globe. Also they go long chocolate and short cats.&nbsp; For a free 30-day trial to the Unhedged newsletter go to: <a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank">https://www.ft.com/unhedgedoffer</a>. You can email Robert Armstrong and Katie Martin at <a href="mailto:unhedged@ft.com" rel="noopener noreferrer" target="_blank">unhedged@ft.com</a>. <a href="https://www.ft.com/content/8d7dcd7c-bdb2-4755-8f93-17db32895661" rel="noopener noreferrer" target="_blank">Read a transcript of this episode on FT.com</a><hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Bonds vs budgets

<description>&lt;p&gt;Short interest in the market is rising. But what are the big players betting against? And what can investors learn from it? Today on the show, Katie Martin joins the editor of the FT’s Alphaville newsletter Robin Wigglesworth to discuss high finance’s low expectations. Also they go short Bloom Energy and short the crypto bros.&amp;nbsp;&lt;/p&gt;&lt;br&gt;&lt;p&gt;To sign up for free to the new FT Alphaville newsletter on substack, go to &lt;a href="http://ftav.substack.com/" rel="noopener noreferrer" target="_blank"&gt;ftav.substack.com&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;For a free 30-day trial to the Unhedged newsletter go to: &lt;a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank"&gt;https://www.ft.com/unhedgedoffer&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;You can email Robert Armstrong and Katie Martin at &lt;a href="mailto:unhedged@ft.com" rel="noopener noreferrer" target="_blank"&gt;unhedged@ft.com&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;&lt;a href="https://www.ft.com/content/c01d23b4-39b9-48e2-81fe-020432a24437" rel="noopener noreferrer" target="_blank"&gt;&lt;strong&gt;Read a transcript of this episode on FT.com&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;hr&gt;&lt;p style='color:grey; font-size:0.75em;'&gt; Hosted on Acast. See &lt;a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'&gt;acast.com/privacy&lt;/a&gt; for more information.&lt;/p&gt;</description>

A look at the strategies of the supposedly smartest people in finance

Short interest in the market is rising. But what are the big players betting against? And what can investors learn from it? Today on the show, Katie Martin joins the editor of the FT’s Alphaville newsletter Robin Wigglesworth to discuss high finance’s low expectations. Also they go short Bloom Energy and short the crypto bros.&nbsp; To sign up for free to the new FT Alphaville newsletter on substack, go to <a href="http://ftav.substack.com/" rel="noopener noreferrer" target="_blank">ftav.substack.com</a>. For a free 30-day trial to the Unhedged newsletter go to: <a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank">https://www.ft.com/unhedgedoffer</a>. You can email Robert Armstrong and Katie Martin at <a href="mailto:unhedged@ft.com" rel="noopener noreferrer" target="_blank">unhedged@ft.com</a>. <a href="https://www.ft.com/content/c01d23b4-39b9-48e2-81fe-020432a24437" rel="noopener noreferrer" target="_blank">Read a transcript of this episode on FT.com</a><hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

What are the hedge funds shorting?

<description>&lt;p&gt;In the morning, Nvidia’s earnings report seemed to have cured the market of its jitters about an artificial intelligence bubble. And then it didn’t. Today on the show, Katie Martin and Rob Armstrong try to figure out if the chipmaker’s numbers are soothing or scary. Also they go long a proposed stimulus cheque and short handbag investment funds.&amp;nbsp;&lt;/p&gt;&lt;br&gt;&lt;p&gt;For a free 30-day trial to the Unhedged newsletter go to: &lt;a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank"&gt;https://www.ft.com/unhedgedoffer&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;You can email Robert Armstrong and Katie Martin at &lt;a href="mailto:unhedged@ft.com" rel="noopener noreferrer" target="_blank"&gt;unhedged@ft.com&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;&lt;a href="https://www.ft.com/content/a040d305-e530-4237-adf7-7f6af3f1c1aa" rel="noopener noreferrer" target="_blank"&gt;&lt;strong&gt;Read a transcript of this episode on FT.com&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;hr&gt;&lt;p style='color:grey; font-size:0.75em;'&gt; Hosted on Acast. See &lt;a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'&gt;acast.com/privacy&lt;/a&gt; for more information.&lt;/p&gt;</description>

Do Nvidia’s huge earnings make the case for or against a bubble?

In the morning, Nvidia’s earnings report seemed to have cured the market of its jitters about an artificial intelligence bubble. And then it didn’t. Today on the show, Katie Martin and Rob Armstrong try to figure out if the chipmaker’s numbers are soothing or scary. Also they go long a proposed stimulus cheque and short handbag investment funds.&nbsp; For a free 30-day trial to the Unhedged newsletter go to: <a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank">https://www.ft.com/unhedgedoffer</a>. You can email Robert Armstrong and Katie Martin at <a href="mailto:unhedged@ft.com" rel="noopener noreferrer" target="_blank">unhedged@ft.com</a>. <a href="https://www.ft.com/content/a040d305-e530-4237-adf7-7f6af3f1c1aa" rel="noopener noreferrer" target="_blank">Read a transcript of this episode on FT.com</a><hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Nvidia's crazy day

<description>&lt;p&gt;The battle between Novo Nordisk and Pfizer to acquire Metsera is over. But is this merger a sign of strength or weakness for the industry? Today on the show, Rob Armstrong talks with US finance editor James Fontanella-Khan about the pressures on drug companies from Washington and the market. Also they go long Nasdaq and short Nasdaq.&amp;nbsp;&lt;/p&gt;&lt;br&gt;&lt;p&gt;For a free 30-day trial to the Unhedged newsletter go to: &lt;a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank"&gt;https://www.ft.com/unhedgedoffer&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;You can email Robert Armstrong and Katie Martin at &lt;a href="mailto:unhedged@ft.com" rel="noopener noreferrer" target="_blank"&gt;unhedged@ft.com&lt;/a&gt;.&lt;/p&gt;&lt;br&gt;&lt;p&gt;&lt;a href="https://www.ft.com/content/fb60908a-d54f-44a2-824e-8c0a43d1645a" rel="noopener noreferrer" target="_blank"&gt;&lt;strong&gt;Read a transcript of this episode on FT.com&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;hr&gt;&lt;p style='color:grey; font-size:0.75em;'&gt; Hosted on Acast. See &lt;a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'&gt;acast.com/privacy&lt;/a&gt; for more information.&lt;/p&gt;</description>

What the bidding war over Metsera says about the drug business

The battle between Novo Nordisk and Pfizer to acquire Metsera is over. But is this merger a sign of strength or weakness for the industry? Today on the show, Rob Armstrong talks with US finance editor James Fontanella-Khan about the pressures on drug companies from Washington and the market. Also they go long Nasdaq and short Nasdaq.&nbsp; For a free 30-day trial to the Unhedged newsletter go to: <a href="https://www.ft.com/unhedgedoffer" rel="noopener noreferrer" target="_blank">https://www.ft.com/unhedgedoffer</a>. You can email Robert Armstrong and Katie Martin at <a href="mailto:unhedged@ft.com" rel="noopener noreferrer" target="_blank">unhedged@ft.com</a>. <a href="https://www.ft.com/content/fb60908a-d54f-44a2-824e-8c0a43d1645a" rel="noopener noreferrer" target="_blank">Read a transcript of this episode on FT.com</a><hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Big deals in Big Pharma

Katie Martin, Robert Armstrong and other markets nerds at the Financial Times explain the big ideas behind what’s happening in finance right now. Every Tuesday and Thursday.<hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Unhedged

Details

Recent Episodes